Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study
Launched by CAIRO UNIVERSITY · Jun 24, 2019
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
To compare safety and efficacy of bipolar plasmakinetic enucleation (BPEP) versus holmium laser enucleation (HoLEP) for management of large BPH (\>80gm).
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients suffering from LUTS secondary to infravesical obstruction from BPH
- • failed medical treatment
- • International Prostate Symptom Score (IPSS) \> 13
- • a peak urinary flow rate (Qmax) \< 15 ml/sec
- • a prostate size ≥ 80 gm
- Exclusion Criteria:
- • presence of a urethral stricture
- • neurological disorder
- • bladder cancer
- • prostate cancer
- • previous history of bladder neck surgery or TURP
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
enmar I Habib, Prof.
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials